ADMA Biologics, Inc.
ADMA
$17.10
-$0.20-1.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.26% | -2.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.26% | -2.34% | |||
| Cost of Revenue | 1.96% | -0.94% | |||
| Gross Profit | 10.03% | -3.53% | |||
| SG&A Expenses | -7.88% | 3.13% | |||
| Depreciation & Amortization | 28.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.92% | 0.88% | |||
| Operating Income | 22.70% | -8.98% | |||
| Income Before Tax | 19.87% | -3.64% | |||
| Income Tax Expenses | -10.20% | 108.48% | |||
| Earnings from Continuing Operations | 27.19% | -75.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.19% | -75.96% | |||
| EBIT | 22.70% | -8.98% | |||
| EBITDA | 21.73% | -8.49% | |||
| EPS Basic | 25.29% | -76.10% | |||
| Normalized Basic EPS | 21.50% | -7.47% | |||
| EPS Diluted | 27.27% | -75.95% | |||
| Normalized Diluted EPS | 21.43% | -6.56% | |||
| Average Basic Shares Outstanding | 1.56% | 0.57% | |||
| Average Diluted Shares Outstanding | 1.61% | -0.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||